Mold Removal Express has published a comprehensive guide designed to help property owners recognize and understand various mold species that may develop in residential and commercial environments. The ...

Discover Marubozu candles: learn their formation, how to interpret them for trading strategies, and their role in predicting ...

PASADENA, Calif., December 02, 2025--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the United States Food and Drug Administration (FDA) has granted Breakthrough ...

The biotech published its latest set of annual results. It's now got several revenue streams that are already significantly boosting the fundamentals. The previous day at market close, Arrowhead took ...

MADISON — In a game where both defenses stood out, it was a special teams play that decided the D1 state championship. A 76-year-yard kickoff return for a touchdown in the final minute of play ...

An Arrowhead Pharmaceuticals RNA drug has passed the regulatory bar for treating a disease that leads to dangerously high levels of fat in the blood, marking the first FDA approval for the company and ...

With a fresh FDA endorsement for its drug plozasiran, California-based Arrowhead Pharmaceuticals has successfully broken through to the commercial realm. Complicating the matter, however, is the fact ...

The Chiefs eventually will choose between the renovation of Arrowhead Stadium in Missouri and the construction of a domed stadium across the border in Kansas. There’s a possibility that a roof could ...

The Kansas City Chiefs have been one of the NFL’s most dominant teams of the last decade, winning three Super Bowl championships and playing in seven straight AFC Championship games. And while the ...

Arrowhead High School's football team advanced to the Division 1 state semifinals for the first time since 2015. The Warhawks overcame a 21-0 deficit to defeat Sussex Hamilton 34-24. A strong ...

The Chiefs continue to move toward an inevitable decision between renovating Arrowhead Stadium and building a new stadium. On Monday, Chiefs owner Clark Hunt addressed the status of the team’s effort ...

Arrowhead Pharmaceuticals has seen its consensus analyst price target increase from $45 to $47.50 per share, reflecting growing confidence in the company's strategy and market positioning. This ...